| W5Y | 表記: | 5'-O-(L-phenylalanylsulfamoyl)adenosine | 組成式: | C19 H23 N7 O7 S | SMILES: | c1ccccc1CC(N)C(=O)NS(=O)(OCC2OC(C(C2O)O)n3c4c(nc3)c(ncn4)N)=O | InChi: | InChI=1S/C19H23N7O7S/c20-11(6-10-4-2-1-3-5-10)18(29)25-34(30,31)32-7-12-14(27)15(28)19(33-12)26-9-24-13-16(21)22-8-23-17(13)26/h1-5,8-9,11-12,14-15,19,27-28H,6-7,20H2,(H,25,29)(H2,21,22,23)/t11-,12+,14+,15+,19+/m0/s1 | 定義日: | 2020-09-29 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 5'-O-(L-phenylalanylsulfamoyl)adenosine |
|
| J3F | 表記: | (5S)-5-[[4-[2-[[7-(diethylamino)-2-oxidanylidene-chromen-4-yl]-methyl-amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | 組成式: | C26 H29 N3 O5 S | SMILES: | CCN(CC)c1ccc2c(OC(=O)C=C2N(C)CCOc3ccc(C[CH]4SC(=O)NC4=O)cc3)c1 | InChi: | InChI=1S/C26H29N3O5S/c1-4-29(5-2)18-8-11-20-21(16-24(30)34-22(20)15-18)28(3)12-13-33-19-9-6-17(7-10-19)14-23-25(31)27-26(32)35-23/h6-11,15-16,23H,4-5,12-14H2,1-3H3,(H,27,31,32)/t23-/m0/s1 | 定義日: | 2021-03-31 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | (5~{S})-5-[[4-[2-[[7-(diethylamino)-2-oxidanylidene-chromen-4-yl]-methyl-amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
|
| Y21 | 表記: | (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid | 組成式: | C20 H22 F N3 O4 | SMILES: | c1(cc4c5c(c1N2CCC(C2)C3(CC3)N)OCC(N5C(C(C(=O)O)=C4)=O)C)F | InChi: | InChI=1S/C20H22FN3O4/c1-10-9-28-17-15-11(6-13(19(26)27)18(25)24(10)15)7-14(21)16(17)23-5-2-12(8-23)20(22)3-4-20/h6-7,10,12H,2-5,8-9,22H2,1H3,(H,26,27)/t10-,12+/m0/s1 | 定義日: | 2021-01-27 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
|
| U8B | 表記: | (2~{S})-2-azanyl-5-[[(2~{R})-3-[(2~{R},5~{R})-5-(hydroxymethyl)-3,6-bis(oxidanylidene)-2-(phenylmethyl)-5-sulfanyl-piperazin-2-yl]sulfanyl-1-(2-hydroxy-2-oxoethylamino)-1-oxidanylidene-propan-2-yl]amino]-5-oxidanylidene-pentanoic acid | 組成式: | C22 H29 N5 O9 S2 | SMILES: | N[CH](CCC(=O)N[CH](CS[C]1(Cc2ccccc2)NC(=O)[C](S)(CO)NC1=O)C(=O)NCC(O)=O)C(O)=O | InChi: | InChI=1S/C22H29N5O9S2/c23-13(18(33)34)6-7-15(29)25-14(17(32)24-9-16(30)31)10-38-22(8-12-4-2-1-3-5-12)20(36)26-21(37,11-28)19(35)27-22/h1-5,13-14,28,37H,6-11,23H2,(H,24,32)(H,25,29)(H,26,36)(H,27,35)(H,30,31)(H,33,34)/t13-,14-,21+,22+/m0/s1 | 定義日: | 2021-01-28 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | (2~{S})-2-azanyl-5-[[(2~{R})-3-[(2~{R},5~{R})-5-(hydroxymethyl)-3,6-bis(oxidanylidene)-2-(phenylmethyl)-5-sulfanyl-piperazin-2-yl]sulfanyl-1-(2-hydroxy-2-oxoethylamino)-1-oxidanylidene-propan-2-yl]amino]-5-oxidanylidene-pentanoic acid |
|
| YQJ | 表記: | N~3~-{4-[3-(dimethylamino)pyrrolidin-1-yl]-6,7-dimethoxyquinazolin-2-yl}-N~1~,N~1~-dimethylpropane-1,3-diamine | 組成式: | C21 H34 N6 O2 | SMILES: | CN(C)CCCNc1nc2cc(OC)c(OC)cc2c(n1)N1CCC(C1)N(C)C | InChi: | InChI=1S/C21H34N6O2/c1-25(2)10-7-9-22-21-23-17-13-19(29-6)18(28-5)12-16(17)20(24-21)27-11-8-15(14-27)26(3)4/h12-13,15H,7-11,14H2,1-6H3,(H,22,23,24) | 定義日: | 2021-03-22 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | N~3~-{4-[3-(dimethylamino)pyrrolidin-1-yl]-6,7-dimethoxyquinazolin-2-yl}-N~1~,N~1~-dimethylpropane-1,3-diamine |
|
| PWB | 表記: | 3',3'-c-[2'FdAMP-2'FdAM(PS)] | 組成式: | C20 H24 F2 N10 O9 P2 S | SMILES: | [NH3+]c1ncnc2n(cnc12)[CH]3O[CH]4CO[P](S)(=O)O[CH]5[CH](F)[CH](O[CH]5CO[P](O)(=O)O[CH]4[CH]3F)n6cnc7c([NH3+])ncnc67 | InChi: | InChI=1S/C20H22F2N10O9P2S/c21-9-13-8(39-19(9)31-5-29-11-15(23)25-3-27-17(11)31)2-37-43(35,44)41-14-7(1-36-42(33,34)40-13)38-20(10(14)22)32-6-30-12-16(24)26-4-28-18(12)32/h3-10,13-14,19-20H,1-2H2,(H,33,34)(H,35,44)(H2,23,25,27)(H2,24,26,28)/p+2/t7-,8-,9-,10-,13-,14-,19-,20-,43-/m1/s1 | 別名: | 9-[(1~{R},6~{R},8~{R},9~{R},10~{R},12~{R},15~{R},17~{R},18~{R})-17-(6-aminopurin-9-yl)-9,18-bis(fluoranyl)-3-oxidanyl-3,12-bis(oxidanylidene)-12-sulfanyl-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.3.0.0^{6,10}]octadecan-8-yl]purin-6-amine | 定義日: | 2020-04-29 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | [9-[(1~{R},6~{R},8~{R},9~{R},10~{R},15~{R},17~{R},18~{R})-17-(6-azaniumylpurin-9-yl)-9,18-bis(fluoranyl)-3-oxidanyl-3,12-bis(oxidanylidene)-12-sulfanyl-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.3.0.0^{6,10}]octadecan-8-yl]purin-6-yl]azanium |
|
| V5M | 表記: | (2E)-3-{4-hydroxy-3-[(E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-5-methoxyphenyl}prop-2-enoic acid | 組成式: | C19 H18 O6 | SMILES: | c1(c(cc(cc1)C=Cc2cc(cc(c2O)OC)C=CC(=O)O)OC)O | InChi: | InChI=1S/C19H18O6/c1-24-16-10-12(4-7-15(16)20)3-6-14-9-13(5-8-18(21)22)11-17(25-2)19(14)23/h3-11,20,23H,1-2H3,(H,21,22)/b6-3+,8-5+ | 定義日: | 2020-06-30 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | (2E)-3-{4-hydroxy-3-[(E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-5-methoxyphenyl}prop-2-enoic acid |
|
| V5P | 表記: | lignostilbene | 組成式: | C16 H16 O4 | SMILES: | c1(ccc(O)c(c1)OC)C=Cc2cc(c(cc2)O)OC | InChi: | InChI=1S/C16H16O4/c1-19-15-9-11(5-7-13(15)17)3-4-12-6-8-14(18)16(10-12)20-2/h3-10,17-18H,1-2H3/b4-3+ | 別名: | 4,4'-[(E)-ethene-1,2-diyl]bis(2-methoxyphenol) | 定義日: | 2020-06-30 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 4,4'-[(E)-ethene-1,2-diyl]bis(2-methoxyphenol) |
|
| XVD | 表記: | 6-[2-chloro-6-(trifluoromethoxy)phenyl]-1H-benzimidazol-2-ol | 組成式: | C14 H8 Cl F3 N2 O2 | SMILES: | n3c2c(cc(c1c(cccc1Cl)OC(F)(F)F)cc2)nc3O | InChi: | InChI=1S/C14H8ClF3N2O2/c15-8-2-1-3-11(22-14(16,17)18)12(8)7-4-5-9-10(6-7)20-13(21)19-9/h1-6H,(H2,19,20,21) | 定義日: | 2021-01-15 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 6-[2-chloro-6-(trifluoromethoxy)phenyl]-1H-benzimidazol-2-ol |
|
| PZK | 表記: | 4-azanyl-6-[1-[(3-fluorophenyl)methyl]pyrazol-4-yl]pyrimidine-5-carbonitrile | 組成式: | C15 H11 F N6 | SMILES: | Nc1ncnc(c2cnn(Cc3cccc(F)c3)c2)c1C#N | InChi: | InChI=1S/C15H11FN6/c16-12-3-1-2-10(4-12)7-22-8-11(6-21-22)14-13(5-17)15(18)20-9-19-14/h1-4,6,8-9H,7H2,(H2,18,19,20) | 定義日: | 2020-05-04 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 4-azanyl-6-[1-[(3-fluorophenyl)methyl]pyrazol-4-yl]pyrimidine-5-carbonitrile |
|
| Q0E | 表記: | 4-azanyl-6-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]pyrimidine-5-carbonitrile | 組成式: | C14 H11 N7 | SMILES: | Nc1ncnc(c2cnn(Cc3cccnc3)c2)c1C#N | InChi: | InChI=1S/C14H11N7/c15-4-12-13(18-9-19-14(12)16)11-6-20-21(8-11)7-10-2-1-3-17-5-10/h1-3,5-6,8-9H,7H2,(H2,16,18,19) | 定義日: | 2020-05-04 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 4-azanyl-6-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]pyrimidine-5-carbonitrile |
|
| Q0H | 表記: | 4-azanyl-6-[1-[[3,4-bis(fluoranyl)phenyl]methyl]pyrazol-4-yl]pyrimidine-5-carbonitrile | 組成式: | C15 H10 F2 N6 | SMILES: | Nc1ncnc(c2cnn(Cc3ccc(F)c(F)c3)c2)c1C#N | InChi: | InChI=1S/C15H10F2N6/c16-12-2-1-9(3-13(12)17)6-23-7-10(5-22-23)14-11(4-18)15(19)21-8-20-14/h1-3,5,7-8H,6H2,(H2,19,20,21) | 定義日: | 2020-05-04 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 4-azanyl-6-[1-[[3,4-bis(fluoranyl)phenyl]methyl]pyrazol-4-yl]pyrimidine-5-carbonitrile |
|
| Q0N | 表記: | 4-azanyl-6-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrimidine-5-carbonitrile | 組成式: | C14 H17 N7 O | SMILES: | Nc1ncnc(c2cnn(CCN3CCOCC3)c2)c1C#N | InChi: | InChI=1S/C14H17N7O/c15-7-12-13(17-10-18-14(12)16)11-8-19-21(9-11)2-1-20-3-5-22-6-4-20/h8-10H,1-6H2,(H2,16,17,18) | 定義日: | 2020-05-04 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 4-azanyl-6-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrimidine-5-carbonitrile |
|
| Q0Q | 表記: | 4-azanyl-6-[1-[(1~{R})-1-phenylethyl]pyrazol-4-yl]pyrimidine-5-carbonitrile | 組成式: | C16 H14 N6 | SMILES: | C[CH](n1cc(cn1)c2ncnc(N)c2C#N)c3ccccc3 | InChi: | InChI=1S/C16H14N6/c1-11(12-5-3-2-4-6-12)22-9-13(8-21-22)15-14(7-17)16(18)20-10-19-15/h2-6,8-11H,1H3,(H2,18,19,20)/t11-/m1/s1 | 定義日: | 2020-05-04 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 4-azanyl-6-[1-[(1~{R})-1-phenylethyl]pyrazol-4-yl]pyrimidine-5-carbonitrile |
|
| Q0T | 表記: | ethyl 2-[4-(6-azanyl-5-cyano-pyrimidin-4-yl)pyrazol-1-yl]ethanoate | 組成式: | C12 H12 N6 O2 | SMILES: | CCOC(=O)Cn1cc(cn1)c2ncnc(N)c2C#N | InChi: | InChI=1S/C12H12N6O2/c1-2-20-10(19)6-18-5-8(4-17-18)11-9(3-13)12(14)16-7-15-11/h4-5,7H,2,6H2,1H3,(H2,14,15,16) | 定義日: | 2020-05-04 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | ethyl 2-[4-(6-azanyl-5-cyano-pyrimidin-4-yl)pyrazol-1-yl]ethanoate |
|
| Q0W | 表記: | 4-azanyl-6-(1-ethylpyrazol-4-yl)pyrimidine-5-carbonitrile | 組成式: | C10 H10 N6 | SMILES: | CCn1cc(cn1)c2ncnc(N)c2C#N | InChi: | InChI=1S/C10H10N6/c1-2-16-5-7(4-15-16)9-8(3-11)10(12)14-6-13-9/h4-6H,2H2,1H3,(H2,12,13,14) | 定義日: | 2020-05-04 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 4-azanyl-6-(1-ethylpyrazol-4-yl)pyrimidine-5-carbonitrile |
|
| Q0Z | 表記: | 5-chloranyl-6-[1-[(3-fluorophenyl)methyl]pyrazol-4-yl]pyrimidin-4-amine | 組成式: | C14 H11 Cl F N5 | SMILES: | Nc1ncnc(c1Cl)c2cnn(Cc3cccc(F)c3)c2 | InChi: | InChI=1S/C14H11ClFN5/c15-12-13(18-8-19-14(12)17)10-5-20-21(7-10)6-9-2-1-3-11(16)4-9/h1-5,7-8H,6H2,(H2,17,18,19) | 定義日: | 2020-05-04 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 5-chloranyl-6-[1-[(3-fluorophenyl)methyl]pyrazol-4-yl]pyrimidin-4-amine |
|
| Q1H | 表記: | 1-(furan-2-ylmethyl)-5-(trifluoromethyl)benzimidazol-2-amine | 組成式: | C13 H10 F3 N3 O | SMILES: | Nc1nc2cc(ccc2n1Cc3occc3)C(F)(F)F | InChi: | InChI=1S/C13H10F3N3O/c14-13(15,16)8-3-4-11-10(6-8)18-12(17)19(11)7-9-2-1-5-20-9/h1-6H,7H2,(H2,17,18) | 定義日: | 2020-05-05 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 1-(furan-2-ylmethyl)-5-(trifluoromethyl)benzimidazol-2-amine |
|
| Q1K | 表記: | 6-(4-methylsulfonylpiperazin-1-yl)-[1,2,4]triazolo[4,3-b]pyridazine | 組成式: | C10 H14 N6 O2 S | SMILES: | C[S](=O)(=O)N1CCN(CC1)c2ccc3nncn3n2 | InChi: | InChI=1S/C10H14N6O2S/c1-19(17,18)15-6-4-14(5-7-15)10-3-2-9-12-11-8-16(9)13-10/h2-3,8H,4-7H2,1H3 | 定義日: | 2020-05-05 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 6-(4-methylsulfonylpiperazin-1-yl)-[1,2,4]triazolo[4,3-b]pyridazine |
|
| Q1Q | 表記: | (6~{R})-2-phenyl-5,6,7,8-tetrahydroquinazolin-6-amine | 組成式: | C14 H15 N3 | SMILES: | N[CH]1CCc2nc(ncc2C1)c3ccccc3 | InChi: | InChI=1S/C14H15N3/c15-12-6-7-13-11(8-12)9-16-14(17-13)10-4-2-1-3-5-10/h1-5,9,12H,6-8,15H2/t12-/m1/s1 | 定義日: | 2020-05-05 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | (6~{R})-2-phenyl-5,6,7,8-tetrahydroquinazolin-6-amine |
|
| MW8 | 表記: | 5-(4-bromophenyl)-~{N}-(4-piperazin-1-ylphenyl)-~{N}-(pyridin-2-ylmethyl)furan-2-carboxamide | 組成式: | C27 H25 Br N4 O2 | SMILES: | Brc1ccc(cc1)c2oc(cc2)C(=O)N(Cc3ccccn3)c4ccc(cc4)N5CCNCC5 | InChi: | InChI=1S/C27H25BrN4O2/c28-21-6-4-20(5-7-21)25-12-13-26(34-25)27(33)32(19-22-3-1-2-14-30-22)24-10-8-23(9-11-24)31-17-15-29-16-18-31/h1-14,29H,15-19H2 | 定義日: | 2019-10-25 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 5-(4-bromophenyl)-~{N}-(4-piperazin-1-ylphenyl)-~{N}-(pyridin-2-ylmethyl)furan-2-carboxamide |
|
| SL7 | 表記: | 5-[[3-[3-(dimethylamino)-1,2,4-oxadiazol-5-yl]-2-oxidanyl-phenyl]methylamino]-2~{H}-indazole-3-carboxylic acid | 組成式: | C19 H18 N6 O4 | SMILES: | CN(C)c1noc(n1)c2cccc(CNc3ccc4n[nH]c(C(O)=O)c4c3)c2O | InChi: | InChI=1S/C19H18N6O4/c1-25(2)19-21-17(29-24-19)12-5-3-4-10(16(12)26)9-20-11-6-7-14-13(8-11)15(18(27)28)23-22-14/h3-8,20,26H,9H2,1-2H3,(H,22,23)(H,27,28) | 定義日: | 2020-03-11 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 5-[[3-[3-(dimethylamino)-1,2,4-oxadiazol-5-yl]-2-oxidanyl-phenyl]methylamino]-2~{H}-indazole-3-carboxylic acid |
|
| SLG | 表記: | 2-chloranyl-4-[2-[[(6-chloranyl-1~{H}-indol-2-yl)carbonyl-methyl-amino]methyl]-5-fluoranyl-phenyl]benzoic acid | 組成式: | C24 H17 Cl2 F N2 O3 | SMILES: | CN(Cc1ccc(F)cc1c2ccc(C(O)=O)c(Cl)c2)C(=O)c3[nH]c4cc(Cl)ccc4c3 | InChi: | InChI=1S/C24H17Cl2FN2O3/c1-29(23(30)22-9-14-2-5-16(25)10-21(14)28-22)12-15-3-6-17(27)11-19(15)13-4-7-18(24(31)32)20(26)8-13/h2-11,28H,12H2,1H3,(H,31,32) | 定義日: | 2020-03-11 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 2-chloranyl-4-[2-[[(6-chloranyl-1~{H}-indol-2-yl)carbonyl-methyl-amino]methyl]-5-fluoranyl-phenyl]benzoic acid |
|
| SLJ | 表記: | 5-[methyl-[(2-propoxypyridin-3-yl)methyl]amino]-2~{H}-indazole-3-carboxylic acid | 組成式: | C18 H20 N4 O3 | SMILES: | CCCOc1ncccc1CN(C)c2ccc3n[nH]c(C(O)=O)c3c2 | InChi: | InChI=1S/C18H20N4O3/c1-3-9-25-17-12(5-4-8-19-17)11-22(2)13-6-7-15-14(10-13)16(18(23)24)21-20-15/h4-8,10H,3,9,11H2,1-2H3,(H,20,21)(H,23,24) | 定義日: | 2020-03-11 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 5-[methyl-[(2-propoxypyridin-3-yl)methyl]amino]-2~{H}-indazole-3-carboxylic acid |
|
| KK6 | 表記: | 5-[3-[[1-(6,7-dimethoxyquinazolin-4-yl)piperidin-4-yl]methyl]-2-oxidanylidene-4H-quinazolin-1-yl]-2-fluoranyl-benzenecarbonitrile | 組成式: | C31 H29 F N6 O3 | SMILES: | COc1cc2ncnc(N3CCC(CC3)CN4Cc5ccccc5N(C4=O)c6ccc(F)c(c6)C#N)c2cc1OC | InChi: | InChI=1S/C31H29FN6O3/c1-40-28-14-24-26(15-29(28)41-2)34-19-35-30(24)36-11-9-20(10-12-36)17-37-18-21-5-3-4-6-27(21)38(31(37)39)23-7-8-25(32)22(13-23)16-33/h3-8,13-15,19-20H,9-12,17-18H2,1-2H3 | 定義日: | 2020-06-24 | 最終更新日: | 2021-05-07 | 公開日: | 2021-05-12 | 識別子(ID): | 5-[3-[[1-(6,7-dimethoxyquinazolin-4-yl)piperidin-4-yl]methyl]-2-oxidanylidene-4~{H}-quinazolin-1-yl]-2-fluoranyl-benzenecarbonitrile |
|